Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes

Current Opinion in Genetics and Development

Volumn 12, Issue 1, 2002, Pages 47-52

  Ho, Alan ^a   Dowdy, Steven F ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN;

CANCER CELL; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL METABOLISM; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CYCLIN-DEPENDENT KINASES; CYCLINS; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; ONCOGENES; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC;

EID: 0036467506     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(01)00263-5     Document Type: Review

References (51)

1. What is the restriction point?
2. Tumor cell proliferation kinetics and tumor growth rate
3. The retinoblastoma protein and cell cycle control
4. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
5. Effects of an Rb mutation in the mouse
6. Requirement for a functional Rb-1 gene in murine development
7. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
8. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system
9. The Rb/E2F pathway: Expanding roles and emerging paradigms
10. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts
11. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
12. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis
13. Cyclin-dependent kinases: Engines, clocks, and microprocessors
14. 1 cyclin-dependent kinase complexes in vivo
15. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
16. Association of human cyclin E with a periodic G1-S phase protein kinase
17. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
18. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia
19. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
20. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
21. Distinct roles for cyclin-dependent kinases in cell cycle control
22. Rb interacts with histone deacetylase to repress transcription
23. Retinoblastoma protein recruits histone deacetylase to repress trancription
24. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
25. E2F-4 switches from p130-p107 and pRB in response to cell cycle reentry
26. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclinD:Cdk4/6 complexes results in active pRb
27. Cumulative effect of phosphorylation of pRB on regulation of E2F activity
28. The Drosophila cyclin D-Cdk4 complex promotes cellular growth
29. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression
30. Identification of G1 kinase activity for cdk6, a novel cyclin D partner
31. D-type cyclin-dependent kinase activity in mammalian cells
32. CDK inhibitors: Positive and negative regulators of G1-phase progression
33. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression
34. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
35. Loss of p16Ink4a with retention of p19Arf prediposes mice to tumorigenesis
36. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL upregulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity
37. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
38. Translational control of p27Kip1 accumulation during the cell cycle
39. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity
40. Regulation of exit from quiescence by p27 and cyclin D1-CDK4
41. Requirements of p27Kip1 for restriction point control of the fibroblast cell cycle
42. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts
43. A CDK-independent function of mammalian Cks1: Targeting of SCF(Skp2) to the CDK inhibitor p27Kip1
44. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27
45. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
46. p27(Kip1) ubiquitination and degradation is regulated by the SCF(SKp2)
47. p45SKP2 promotes p27Kip1 degradation andi induces S phase in quiescent cells
48. Requirement for p27Kip1 in retinoblastoma protein-mediated senescence
49. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice
50. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
51. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor of p27(Kip1)